Literature DB >> 20139112

Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction.

Kevin C Lord1, Sylvia K Shenouda, Elizabeth McIlwain, Dimitrios Charalampidis, Pamela A Lucchesi, Kurt J Varner.   

Abstract

AIMS: Our aim was to test the hypothesis that the repeated, binge administration of methamphetamine would produce oxidative stress in the myocardium leading to structural remodeling and impaired left ventricular function. METHODS AND
RESULTS: Echocardiography and Millar pressure-volume catheters were used to monitor left ventricular structure and function in rats subjected to four methamphetamine binges (3 mg/kg, iv for 4 days, separated by a 10-day drug-free period). Hearts from treated and control rats were used for histological or proteomic analysis. When compared with saline treatment, four methamphetamine binges produced eccentric left ventricular hypertrophy. The drug also significantly impaired systolic function (decreased fractional shortening, ejection fraction, and adjusted maximal power) and produced significant diastolic dysfunction (increased -dP/dt and tau). Dihydroethedium staining showed that methamphetamine significantly increased (285%) the levels of reactive oxygen species in the left ventricle. Treatment with methamphetamine also resulted in the tyrosine nitration of myofilament (desmin, myosin light chain) and mitochondrial (ATP synthase, NADH dehydrogenase, cytochrome c oxidase, prohibitin) proteins. Treatment with the superoxide dismutase mimetic, tempol in the drinking water prevented methamphetamine-induced left ventricular dilation and systolic dysfunction; however, tempol (2.5 mM) did not prevent the diastolic dysfunction. Tempol significantly reduced, but did not eliminate dihydroethedium staining in the left ventricle, nor did it prevent the tyrosine nitration of mitochondrial and contractile proteins.
CONCLUSION: This study shows that oxidative stress plays a significant role in mediating methamphetamine-induced eccentric left ventricular dilation and systolic dysfunction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20139112      PMCID: PMC2883898          DOI: 10.1093/cvr/cvq043

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  33 in total

1.  Increased expression of cytoskeletal, linkage, and extracellular proteins in failing human myocardium.

Authors:  A Heling; R Zimmermann; S Kostin; Y Maeno; S Hein; B Devaux; E Bauer; W P Klövekorn; M Schlepper; W Schaper; J Schaper
Journal:  Circ Res       Date:  2000-04-28       Impact factor: 17.367

Review 2.  Role of catechol autooxidation in the degeneration of dopamine neurons.

Authors:  B Fornstedt
Journal:  Acta Neurol Scand Suppl       Date:  1990

3.  N-Acetylcysteine amide protects against methamphetamine-induced oxidative stress and neurotoxicity in immortalized human brain endothelial cells.

Authors:  Xinsheng Zhang; Atrayee Banerjee; William A Banks; Nuran Ercal
Journal:  Brain Res       Date:  2009-04-15       Impact factor: 3.252

4.  Cardiovascular responses elicited by the "binge" administration of methamphetamine.

Authors:  Kurt J Varner; Brian A Ogden; Joseph Delcarpio; Suzanne Meleg-Smith
Journal:  J Pharmacol Exp Ther       Date:  2002-04       Impact factor: 4.030

5.  Relaxation abnormalities in cardiac hypertrophy.

Authors:  W J Paulus; D L Brutsaert
Journal:  Eur Heart J       Date:  1982-04       Impact factor: 29.983

Review 6.  Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment.

Authors:  C Davidson; A J Gow; T H Lee; E H Ellinwood
Journal:  Brain Res Brain Res Rev       Date:  2001-08

7.  Oxidatively damaged proteins of heart mitochondrial electron transport complexes.

Authors:  K B Choksi; W H Boylston; J P Rabek; W R Widger; J Papaconstantinou
Journal:  Biochim Biophys Acta       Date:  2004-03-02

8.  Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?

Authors:  Mevan Wijetunga; Todd Seto; Joseph Lindsay; Irwin Schatz
Journal:  J Toxicol Clin Toxicol       Date:  2003

9.  Effects of chronic methamphetamine exposure on heart function in uninfected and retrovirus-infected mice.

Authors:  Qianli Yu; Sergio Montes; Douglas F Larson; Ronald R Watson
Journal:  Life Sci       Date:  2002-07-12       Impact factor: 5.037

10.  Cardiomyopathy associated with the smoking of crystal methamphetamine.

Authors:  R Hong; E Matsuyama; K Nur
Journal:  JAMA       Date:  1991-03-06       Impact factor: 56.272

View more
  22 in total

Review 1.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

2.  Comparison of the behavioral and cardiovascular effects of mephedrone with other drugs of abuse in rats.

Authors:  Kurt J Varner; Kyle Daigle; Peter F Weed; Peter B Lewis; Sarah E Mahne; Ananthakrishnan Sankaranarayanan; Peter J Winsauer
Journal:  Psychopharmacology (Berl)       Date:  2012-09-13       Impact factor: 4.530

3.  Findings on 3D speckle tracking echocardiography in asymptomatic methamphetamine abusers.

Authors:  Li-Juan Zhang; Ke-Qi Chen; Yun-Yan Shi; Xiao-Ling Qiao; Lian-You Wang; Xiao-Zhi Zheng
Journal:  Int J Cardiovasc Imaging       Date:  2018-05-28       Impact factor: 2.357

4.  Pituitary adenylate cyclase-activating polypeptide (PACAP) protects against mitoxantrone-induced cardiac injury in mice.

Authors:  Venkat Subramaniam; Gin Chuang; Huijing Xia; Brendan Burn; Jessica Bradley; Jerome L Maderdrut; David H Coy; Kurt J Varner
Journal:  Peptides       Date:  2017-07-15       Impact factor: 3.750

Review 5.  Drug-induced mitochondrial dysfunction and cardiotoxicity.

Authors:  Zoltán V Varga; Peter Ferdinandy; Lucas Liaudet; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-18       Impact factor: 4.733

6.  Methamphetamine and HIV-Tat alter murine cardiac DNA methylation and gene expression.

Authors:  Christopher A Koczor; Earl Fields; Mark J Jedrzejczak; Zhe Jiao; Tomika Ludaway; Rodney Russ; Joan Shang; Rebecca A Torres; William Lewis
Journal:  Toxicol Appl Pharmacol       Date:  2015-08-22       Impact factor: 4.219

7.  Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study.

Authors:  Tracy L Hellem; Young-Hoon Sung; Xian-Feng Shi; Marjorie A Pett; Gwen Latendresse; Jubel Morgan; Rebekah S Huber; Danielle Kuykendall; Kelly J Lundberg; Perry F Renshaw
Journal:  J Dual Diagn       Date:  2015

Review 8.  Methamphetamine-associated cardiomyopathy.

Authors:  Sekon Won; Robert A Hong; Ralph V Shohet; Todd B Seto; Nisha I Parikh
Journal:  Clin Cardiol       Date:  2013-08-27       Impact factor: 2.882

9.  Serum Antioxidants Are Associated with Serum Reproductive Hormones and Ovulation among Healthy Women.

Authors:  Sunni L Mumford; Richard W Browne; Karen C Schliep; Jonathan Schmelzer; Torie C Plowden; Kara A Michels; Lindsey A Sjaarda; Shvetha M Zarek; Neil J Perkins; Lynne C Messer; Rose G Radin; Jean Wactawski-Wende; Enrique F Schisterman
Journal:  J Nutr       Date:  2015-11-18       Impact factor: 4.798

10.  A proteomic view of isoproterenol induced cardiac hypertrophy: prohibitin identified as a potential biomarker in rats.

Authors:  Debabrata Chowdhury; Anjana Devi Tangutur; Tarak Nath Khatua; Priyanka Saxena; Sanjay K Banerjee; Manika Pal Bhadra
Journal:  J Transl Med       Date:  2013-05-24       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.